Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Profit After Tax (2019 - 2026)

Biodesix filings provide 8 years of Profit After Tax readings, the most recent being -$7.8 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 29.8% to -$7.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$32.0 million, a 20.93% increase, with the full-year FY2025 number at -$35.3 million, up 17.86% from a year prior.
  • Profit After Tax hit -$7.8 million in Q1 2026 for Biodesix, down from -$4.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$4.0 million in Q4 2025 to a low of -$20.3 million in Q4 2022.
  • Median Profit After Tax over the past 5 years was -$11.1 million (2025), compared with a mean of -$12.0 million.
  • Biggest five-year swings in Profit After Tax: tumbled 123.9% in 2022 and later skyrocketed 55.29% in 2023.
  • Biodesix's Profit After Tax stood at -$20.3 million in 2022, then skyrocketed by 55.29% to -$9.1 million in 2023, then grew by 9.26% to -$8.3 million in 2024, then soared by 51.76% to -$4.0 million in 2025, then plummeted by 95.8% to -$7.8 million in 2026.
  • The last three reported values for Profit After Tax were -$7.8 million (Q1 2026), -$4.0 million (Q4 2025), and -$8.7 million (Q3 2025) per Business Quant data.